EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

HLA ‐haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties

Stefano Giardino iD, Dirk-Jan Eikema, Brian Piepenbroek, Mattia Algeri, Mouhab Ayas, Maura Faraci, Abdelghani Tbakhi, Marco Zecca, Mohammed Essa, Bénédicte Neven, Yves Bertrand, Gaurav Kharya und 16 weitere

American Journal of Hematology · 2024

DOI: 10.1002/ajh.27293 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Stefano Giardino und 27 weiteren Autor:innen. Beteiligte Einrichtung: Hematopoietic Stem Cell Transplantation Unit, Department of Pediatric Hematology and Oncology, IRCCS Istituto Giannina Gaslini, Genoa, Italy. Hauptthemen laut MEDLINE: Anemia, Aplastic. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Haploidentical stem cell transplantation (haplo‐SCT) represents the main alternative for children with inherited bone marrow failure syndrome (I‐BMF) lacking a matched donor. This retrospective study, conducted on behalf of the EBMT SAAWP and PDWP, aims to report the current outcomes of haplo‐SCT in I‐BMFs, comparing the different in vivo and ex vivo T‐cell depletion approaches. One hundred and sixty‐two I‐BMF patients who underwent haplo‐SCT (median age 7.4 years) have been registered. Fanconi Anemia was the most represented diagnosis (70.1%). Based on different T‐cell depletion (TCD) approaches, four categories were identified: (1) TCRαβ + /CD19 + ‐depletion (43.8%); (2) T‐repleted with post‐transplant Cyclophosphamide (PTCy, 34.0%); (3) In‐vivo T‐depletion with ATG/alemtuzumab (14.8%); (4) CD34 + positive selection (7.4%). The cumulative incidences (CI) of neutrophil and platelet engraftment were 84% and 76% respectively, while that of primary and secondary graft failure was 10% and 8% respectively. The 100‐day CI of acute GvHD grade III‐IV(95% CI) was 13%, while the 24‐month CI of extensive chronic GvHD was 4%. After a median follow‐up of 43.4 months, the 2‐year overall survival(OS) and GvHD/Rejection‐free Survival (GRFS) probabilities are 67% and 53%, respectively. The TCR CD3 + αβ + /CD19 + depletion group showed a significantly lower incidence of both acute and chronic GvHD and higher OS (79%; p0 . 013 ) and GRFS (71%; p < . 001 ), while no significant differences in outcomes have been observed by different diagnosis and conditioning regimens. This large retrospective study supports the safety and feasibility of haplo‐SCT in I‐BMF patients. TCRαβ + /CD19 + depletion offers higher chances of patients' survival, with a significantly lower risk of severe a‐ and c‐GvHD in I‐BMFs compared to other platforms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, AplasticHumansChildRetrospective StudiesMaleFemaleChild, PreschoolAdolescentInfantHematopoietic Stem Cell TransplantationGraft vs Host DiseaseBone Marrow Failure DisordersTransplantation, HaploidenticalLymphocyte DepletionTransplantation ConditioningHemoglobinuria, ParoxysmalFanconi AnemiaBone Marrow DiseasesHLA Antigens

Substanzen

HLA Antigens

Autor:innen und Institutionen

  • Hematopoietic Stem Cell Transplantation Unit, Department of Pediatric Hematology and Oncology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
  • Statistical Unit and Data Office, European Society for Blood and Marrow Transplantation (EBMT), Leiden, The Netherlands.
  • EBMT Leiden Study Unit, Leiden, The Netherlands.
  • Department of Pediatric Haematology and Oncology & Stem and Gene Therapy, IRRCS Bambino Gesù Children's Hospital, Rome, Italy.
  • Department of Health Sciences, Magna Graecia University, Catanzaro, Italy.
  • King Faisal Specialist Hospital and Research Center, Department of Pediatric Hematology Oncology, Riyadh, Saudi Arabia.

ORCID-Profile: Stefano Giardino, Antonio Risitano, Régis Peffault de Latour

Zitieren

APA

Giardino, S., Eikema, D. J., Piepenbroek, B., Algeri, M., Ayas, M., Faraci, M., Tbakhi, A., Zecca, M., Essa, M., Neven, B., Bertrand, Y., Kharya, G., Bykova, T., Lawson, S., Petrini, M., Mohseny, A., Rialland, F., James, B., Colita, A., …, & de Latour, R. P. (2024). HLA ‐haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties. American Journal of Hematology. https://doi.org/10.1002/ajh.27293

Vancouver

Giardino S, Eikema DJ, Piepenbroek B, Algeri M, Ayas M, Faraci M, et al. HLA ‐haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties. American Journal of Hematology. 2024. doi:10.1002/ajh.27293

BibTeX
@article{Giardino2024,
  author = {Giardino, Stefano and Eikema, Dirk-Jan and Piepenbroek, Brian and Algeri, Mattia and Ayas, Mouhab and Faraci, Maura and Tbakhi, Abdelghani and Zecca, Marco and Essa, Mohammed and Neven, Bénédicte and Bertrand, Yves and Kharya, Gaurav and Bykova, Tatiana and Lawson, Sarah and Petrini, Mario and Mohseny, Alexander and Rialland, Fanny and James, Beki and Colita, Anca and Fahd, Mony and Cesaro, Simone and Schulz, Ansgar and Kleinschmidt, Katharina and Kałwak, Krzysztof and Corbacioglu, Selim and Dufour, Carlo and Risitano, Antonio and de Latour, Régis Peffault},
  title = {HLA ‐haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties},
  journal = {American Journal of Hematology},
  year = {2024},
  doi = {10.1002/ajh.27293}
}
Kostenlos starten →